Get Benzinga's Best Trading Ideas For Free

Search

AmSurg Corp.’s (AMSG) Estimates Lowered


Analyst Robert Hawkins at Stifel Nicolaus has released an update on AmSurg Corp. (NASDAQ: AMSG).

According to Stifel Nicolaus, the company’s earnings face significant headwinds this year. Stifel Nicolaus has lowered the estimates for the company after reviewing the items in the 10K.

The EPS for 2010 has been lowered from $1.84 to $1.78. Stifel Nicolaus also estimates a higher interest rate, and a drop of 50 basis points in margins.

Stifel Nicolaus continues to rate AmSurg Corp. as a Buy, with a price target of $25.



There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.

Post new comment

The content of this field is kept private and will not be shown publicly.